The Valley Desk

NCT06914609 · Interventional trial

REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome

Overall registry status Active not recruiting

Phase 3

Conditions Angelman Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov